Long-term efficacy of empagliflozin as an add-on treatment for chronic SIAD: a case report and literature review.
Fabio BiolettoEmanuele VaraldoNunzia PrencipeAndrea BensoAlessandro Maria BertonPublished in: Hormones (Athens, Greece) (2023)
SGLT2 inhibitors might represent an effective treatment for SIAD, even in the long term. Specific clinical trials are needed to confirm this result.